GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Extendicare Inc (OTCPK:EXETF) » Definitions » Cash, Cash Equivalents, Marketable Securities

Extendicare (Extendicare) Cash, Cash Equivalents, Marketable Securities : $56.0 Mil (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Extendicare Cash, Cash Equivalents, Marketable Securities?

Extendicare's quarterly cash, cash equivalents, marketable securities increased from Jun. 2023 ($67.19 Mil) to Sep. 2023 ($71.13 Mil) but then stayed the same from Sep. 2023 ($71.13 Mil) to Dec. 2023 ($56.04 Mil).

Extendicare's annual cash, cash equivalents, marketable securities increased from Dec. 2021 ($81.74 Mil) to Dec. 2022 ($123.14 Mil) but then declined from Dec. 2022 ($123.14 Mil) to Dec. 2023 ($56.04 Mil).


Extendicare Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Extendicare's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Extendicare Cash, Cash Equivalents, Marketable Securities Chart

Extendicare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.73 140.49 81.74 123.14 56.04

Extendicare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.14 77.06 67.19 71.13 56.04

Extendicare Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Extendicare  (OTCPK:EXETF) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Extendicare Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Extendicare's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Extendicare (Extendicare) Business Description

Industry
Traded in Other Exchanges
Address
3000 Steeles Avenue East, Suite 700, Markham, ON, CAN, L3R 9W2
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The company has three main business segments namely Long-term Care, Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides more than 9 million hours of home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada.

Extendicare (Extendicare) Headlines

From GuruFocus

Extendicare Appoints Dr. Michael R. Guerriere as New President and CEO

By GlobeNewswire GlobeNewswire 09-11-2018

Extendicare Announces Normal Course Issuer Bid

By GlobeNewswire GlobeNewswire 06-27-2022

Extendicare Announces December 2018 Dividend of C$0.04 per Share

By GlobeNewswire GlobeNewswire 12-14-2018

Extendicare Provides Business Update Related to COVID-19

By GlobeNewswire GlobeNewswire 04-28-2020

Extendicare Announces December 2020 Dividend of C$0.04 per Share

By GlobeNewswire GlobeNewswire 12-17-2020

Extendicare Announces 2021 First Quarter Results

By GlobeNewswire GlobeNewswire 05-12-2021